To ask the Secretary of State for Health
(1) what plans her Department has to introduce a fast track National Institute for Clinical Excellence appraisal process to ensure cancer patients no longer have to wait for long periods before those treatments have been appraised;
(2) what plans her Department has to reduce the time it takes for National Institute for Clinical Excellence to appraise treatments that have shown to be safe and effective in clinical trials and licensed for use in the UK; and if she will make a statement;
(3) what plans her Department has to reduce the time it takes for National Institute for Health and Clinical Excellence to appraise vital cancer treatments; and if she will make a statement.
The National Institute for Health and Clinical Excellence (NICE) is an independent organisation, which develops its guidance after careful consideration of the available evidence and in consultation with stakeholders. The process by which it develops its guidance is a matter for NICE. Its processes have been developed through wide consultation, are transparent and have been endorsed by the World Health Organisation. NICE reviews its processes regularly in order to identify opportunities for efficiencies in the way they are applied.
NICE can only issue guidance on treatments that are licensed for use in the United Kingdom.